caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1346280906

Manuel Melendez RamirezMD

General PracticeManati, PRI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Manuel Melendez Ramirez's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Lorraine Vazquez
Diagnostic Radiology · Manati, PR
1735
Laboratorio Clinico Tierras Nuevas Inc
Clinical Laboratory · Manati, PR
1340
DORADO HEALTH INC1137
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
DOCTORS CENTER HOSPITAL INC3060
DORADO HEALTH INC2149
Antonio Diaz
Diagnostic Radiology · San Juan, PR
1631
Yadira Vazquez Figuer
Diagnostic Radiology · Manati, PR
1529
Laboratorio Clinico Tierras Nuevas Inc
Clinical Laboratory · Manati, PR
1230
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
70
Unique beneficiaries
—
Total services
124
Distinct HCPCS
1
Medicare payment
$7K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 381 General Practice providers in PR — top quintile (cohort median 47).
PRESCRIBING · PART D · 2024
Total Rx claims
9,589
Beneficiaries
—
Total drug cost
$527K
Distinct drugs
140
Brand share
18.8%
Top prescribed drugs
Famotidine591 claims
Gabapentin546 claims
Omeprazole354 claims
Atorvastatin Calcium349 claims
Levothyroxine Sodium348 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.